loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for (S)-2-amino-3-phenylpropanoate

    Client Email Product
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

    Virtual Booth

    Contact Supplier

    View Presentation

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    SuanFarma is present in all origins: Natural, Chemical & Biotechnological.

    Virtual Booth

    Contact Supplier

    Coral

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Menu

    (S)-2-amino-3-phenylpropanoate

    ACTIVE PHARMA INGREDIENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 104Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Relief Announces U.S. Launch of PKU GOLIKE
    Relief Announces U.S. Launch of PKU GOLIKE

    10 Oct 2022

    // ACCESSWIRE

    https://www.accesswire.com/719588/Relief-Announces-US-Launch-of-PKU-GOLIKE

    ACCESSWIRE
    10 Oct 2022
    Share Share
    Synlogic Announces Positive Phase 2 Data for SYNB1618
    Synlogic Announces Positive Phase 2 Data for SYNB1618

    20 Sep 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/synlogic-announces-positive-phase-2-data-demonstrating-reduction-in-plasma-phenylalanine-levels-in-patients-with-phenylketonuria-301380078.html

    PRNEWSWIRE
    20 Sep 2021
    Share Share
    Jnana nets $50M to push newly unveiled PKU program
    Jnana nets $50M to push newly unveiled PKU program

    19 Aug 2021

    // A. Al Idrus FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/jnana-nets-50m-to-push-newly-unveiled-pku-program-expand-into-more-hard-to-drug-targets

    A. Al Idrus FIERCEBIOTECH
    19 Aug 2021
    Share Share
    BioMarin begins patient dosing in phI/II study of BMN 307
    BioMarin begins patient dosing in phI/II study of BMN 307

    25 Sep 2020

    // S. Rafael PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=131397&sid=2

    S. Rafael PHARMABIZ
    25 Sep 2020
    Share Share
    European Medicines Agency (EMA) publishes information on excipients for labeling & package leaflet of human medicines
    European Medicines Agency (EMA) publishes information on excipients for labeling & package leaflet of human medicines

    01 Jan 2019

    // EMA

    https://www.ema.europa.eu/en/human-regulatory/marketing-authorisation/product-information/reference-guidelines/excipients-labelling

    EMA
    01 Jan 2019
    Share Share
    Judge forces NHS England rethink on Kuvan
    Judge forces NHS England rethink on Kuvan

    09 Aug 2017

    // Phil Taylor PMLIVE

    http://www.pmlive.com/pharma_news/judge_forces_nhs_england_rethink_on_kuvan_1200963

    Phil Taylor PMLIVE
    09 Aug 2017
    Share Share